Cell-Free DNA and DNase Activity in Dogs with Immune-Mediated Hemolytic Anemia

Area of Science:

• Veterinary Medicine
• Immunology
• Hematology

Background:

• Immune-mediated hemolytic anemia (IMHA) in dogs carries a high risk of thrombosis.
• Neutrophilia and necrosis are common in IMHA, leading to increased cell-free DNA (cfDNA).
• cfDNA has prothrombotic properties, potentially contributing to hypercoagulability in IMHA.

Purpose of the Study:

• To investigate cfDNA concentrations and DNase activity in dogs with IMHA.
• To compare cfDNA levels and DNase activity between IMHA dogs and healthy controls.
• To assess the association between cfDNA and clinical outcomes like death and thrombosis.

Main Methods:

• A prospective observational study included 28 dogs with IMHA and 20 healthy controls.
• Plasma cfDNA was quantified using PicoGreen fluorescence.
• Serum DNase activity was measured via radial diffusion assay, and clinical outcomes were recorded.

Main Results:

• Dogs with IMHA had significantly higher plasma cfDNA concentrations than healthy controls (P=0.0084).
• No significant difference in serum DNase activity was observed between IMHA cases and controls (P=0.36).
• Higher cfDNA concentration was associated with an increased risk of death (P=0.03) but not thrombosis (P=0.57).

Conclusions:

• Elevated cfDNA in dogs with IMHA is likely due to increased release rather than impaired degradation.
• cfDNA concentration may serve as a potential prognostic indicator for mortality in IMHA dogs.
• Further studies with larger populations are needed to confirm the prognostic value of cfDNA in IMHA.